Sources | Names Used |
---|---|
CTRPv2 | alisertib:navitoclax (2:1 mol/mol) |
PharmacoGx | alisertib:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HDAC2 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-09 |
mRNA | ARHGAP33 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-09 |
mRNA | KMT5C | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-09 |
mRNA | GP1BB | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-09 |
mRNA | KIF1A | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-09 |
mRNA | SUGP2 | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-09 |
mRNA | MBTD1 | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-09 |
mRNA | ILF3 | CTRPv2 | pan-cancer | AAC | 0.23 | 5e-09 |
mRNA | MYB | CTRPv2 | pan-cancer | AAC | 0.24 | 5e-09 |
mRNA | DNMT3A | CTRPv2 | pan-cancer | AAC | 0.22 | 6e-09 |